LORI SALLEY — Lobbyist Profile | Poliscope

LORI SALLEY

Reported covered position: Research Asst. House Sml Bus. Cmte

Filings

Clients

Firms

Years active

2010–2010

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
CHILDREN'S CANCER CAUSE	4	2010

Lobbying firms

Firm	Filings	Years
CHILDREN'S CANCER CAUSE	4	2010

Bills explicitly cited in this lobbyist’s assigned issues (2)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 2109

Childhood Cancer Survivorship Research and Quality of Life Act of 2009

Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text

Reauthorization of the Best Pharmaceuticals for Children Act, H.R. 2109 Childhood Cancer Survivorship legislation, health care reform benefits

H.R. 2109

Childhood Cancer Survivorship Research and Quality of Life Act of 2009

Client: CHILDREN'S CANCER CAUSE · Firm: CHILDREN'S CANCER CAUSE

Open original LDA filing ↗

Cited source text

H.R. 2109 -- Childhood Cancer Survivorship Research and Quality of Life Act, all titles Appropriations -- Labor/HHS bill for Cures Acceleration Network

Original LDA source filings (4)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE

2010 · fourth_quarter · 4A

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Support for legislation to provide resources and research to assist survivors of childhood cancer.

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

CHILDREN'S CANCER CAUSE via CHILDREN'S CANCER CAUSE

2010 · fourth_quarter · 4A

Firm income: —Client expense: —Open original LDA filing ↗

Source: Senate LDA